LOTENSIN HCT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lotensin Hct, and what generic alternatives are available?
Lotensin Hct is a drug marketed by Validus Pharms and is included in one NDA.
The generic ingredient in LOTENSIN HCT is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lotensin Hct
A generic version of LOTENSIN HCT was approved as benazepril hydrochloride; hydrochlorothiazide by ANI PHARMS on February 11th, 2004.
Summary for LOTENSIN HCT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 13 |
Patent Applications: | 3,926 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOTENSIN HCT |
What excipients (inactive ingredients) are in LOTENSIN HCT? | LOTENSIN HCT excipients list |
DailyMed Link: | LOTENSIN HCT at DailyMed |
Recent Clinical Trials for LOTENSIN HCT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nanjing Children's Hospital | Phase 2 |
University of Nebraska | Phase 4 |
Children's Hospital of Fudan University | Phase 1/Phase 2 |
Pharmacology for LOTENSIN HCT
Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for LOTENSIN HCT
US Patents and Regulatory Information for LOTENSIN HCT
Expired US Patents for LOTENSIN HCT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-004 | May 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-003 | May 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-001 | May 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOTENSIN HCT | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 020033-002 | May 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTENSIN HCT
See the table below for patents covering LOTENSIN HCT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0119955 | 3-(5-AMINOPENTYL)-AMINO-1-BENZAZEPIN-2-ONE-1-ALCANOIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL PREPARATION AS WELL AS THEIR THERAPEUTIC USE | ⤷ Try a Trial |
Canada | 1196636 | BENZAZEPIN-2-ONES (BENZAZEPIN-2-ONES) | ⤷ Try a Trial |
Australia | 2443084 | ⤷ Try a Trial | |
Greece | 77256 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |